SPONSORED:

House Dems to unveil drug pricing measure ahead of Biden package

House Dems to unveil drug pricing measure ahead of Biden package
© Greg Nash

House Democrats are preparing to reintroduce major legislation to lower drug prices ahead of President BidenJoe BidenBiden says Beau's assessment of first 100 days would be 'Be who you are' Biden: McCarthy's support of Cheney ouster is 'above my pay grade' Conservative group sues over prioritization of women, minorities for restaurant aid MORE's unveiling of his American Families Plan, which could include the proposals.

House Democrats will introduce sections of their signature drug pricing measure, known as H.R. 3, which allows the secretary of Health and Human Services to negotiate lower prices, "as early as tomorrow," according to a senior Democratic aide. 

The drug pricing provisions could also be included in the American Families Plan that Biden is expected to unveil next week, a large package also including child care, paid leave and other priorities. 

ADVERTISEMENT

However, advocates and lawmakers were on guard on Wednesday over rumors that the drug pricing legislation might not make it into Biden's package.  

Speaker Nancy PelosiNancy PelosiOn The Money: Inflation jumps at fastest pace since 2008 | Biden 'encouraged' on bipartisan infrastructure deal Overnight Health Care: CDC approves Pfizer vaccine for adolescents aged 12-15 | House moderates signal concerns with Pelosi drug pricing bill | Panel blasts COVID-19 response Biden 'encouraged' by meeting with congressional leaders on infrastructure MORE (D-Calif.) has been a major proponent of including drug pricing in the package. 

"Lowering health costs and prescription drug prices for America’s families is a top priority of House Democrats with overwhelming bipartisan support among the American people, and we expect it to be part of the American Families Plan," said Pelosi spokesman Henry Connelly. 

The White House did not immediately respond to a request for comment. 

The House drug pricing bill, which could be unveiled as soon as Thursday, will be silent, though, on how to spend the billions of dollars in savings. A debate is playing out among Democrats over whether to spend the savings on Medicare enhancements — such as adding vision, hearing and dental benefits and lowering the eligibility age — or on making permanent the extra financial assistance through ObamaCare in the earlier Biden relief package.

ADVERTISEMENT

Sens. Debbie StabenowDeborah (Debbie) Ann StabenowThe Hill's Morning Report - Presented by Emergent BioSolutions - House GOP drama intensifies; BIden sets new vax goal Overnight Health Care: Biden sets goal of at least one shot to 70 percent of adults by July 4 | White House to shift how it distributes unallocated vaccines to states The Hill's Morning Report - Presented by Emergent BioSolutions - Can Cheney defy the odds and survive again? MORE (D-Mich.), Sherrod BrownSherrod Campbell BrownSenate Democrats offer bill to scrap tax break for investment managers Wyden: Funding infrastructure with gas tax hike a 'big mistake' Sherrod Brown calls Rand Paul 'kind of a lunatic' for not wearing mask MORE (D-Ohio) and Tammy BaldwinTammy Suzanne BaldwinSenate Democrats offer bill to scrap tax break for investment managers Senate Democrats push Biden over raising refugee cap House Dems to unveil drug pricing measure ahead of Biden package MORE (D-Wis.) earlier on Wednesday reintroduced legislation to lower the Medicare eligibility age to 50, and Sen. Bernie SandersBernie SandersOvernight Health Care: CDC approves Pfizer vaccine for adolescents aged 12-15 | House moderates signal concerns with Pelosi drug pricing bill | Panel blasts COVID-19 response Briahna Joy Gray: Warren not endorsing Sanders in 2020 was 'really frustrating' House moderates signal concerns with Pelosi drug pricing bill MORE (I-Vt.) has been making a similar push.

Such an expansion of Medicare would be a major addition to the Biden package, though, and some advocates have expected smaller coverage moves.

Still, Stabenow told reporters she has made the case to the White House to include her measure. 

"I would love to see that happen," she said. "I've talked with folks at the White House."

The drug pricing measure is fiercely opposed by the pharmaceutical industry, which argues it would harm innovation that leads to the development of new drugs.

ADVERTISEMENT

The Pharmaceutical Research and Manufacturers of America, ahead of the coming drug pricing push, put out an alternative agenda earlier this month, with far less sweeping changes, and calling on insurers to do more to cover costs. 

On the other end of the spectrum, Rep. Lloyd DoggettLloyd Alton DoggettBattle lines drawn over Biden's support for vaccine waivers Biden backs COVID-19 vaccine patent waivers Overnight Health Care: Biden sets goal of at least one shot to 70 percent of adults by July 4 | White House to shift how it distributes unallocated vaccines to states MORE (D-Texas) pushed in a statement Wednesday to strengthen HR3 even further, including expanding the number of drugs subject to negotiation. 

"Consumers have to cut pills and skip prescriptions while Big Pharma refuses to cut into its massive profit margins," Doggett said in a statement. "There are multiple rumors about attempts to weaken HR 3 even further." 

Rep. Peter WelchPeter Francis WelchAllow Medicare to negotiate on behalf of patients to lower drug prices Democrats push to add drug pricing, Medicare measures to Biden plan House Dems to unveil drug pricing measure ahead of Biden package MORE (D-Vt.) added that getting the measure through the House and Senate, even with only Democratic votes, will be a challenge, but the push needs to be made. 

"Among my Demcoractic colleagues there's some apprehension about taking on pharma," he said.

Updated at 5:44 p.m.